Key takeaways

• The global community of heart rhythm specialists will unite in Paris for EHRA 2026, the annual congress of the European Heart Rhythm Association (EHRA).

• With a theme of ‘Illuminating arrhythmia management’, the programme will cover the latest cutting-edge technologies and treatments, and how these can be best implemented into routine care.

• With an unprecedented number of submissions, the Late-Breaking Science programme promises to be a congress highlight, with the presentation of potentially practice-changing data.

Sophia Antipolis, France – 31 March 2026: The global community of heart rhythm specialists will unite in Paris from 12 to 14 April 2026 for EHRA 2026, the annual congress of the European Heart Rhythm Association (EHRA), a branch of the European Society of Cardiology (ESC).

“With around one in three to five people likely to develop a heart rhythm disorder in their lifetime,¹ gathering heart rhythm specialists together to expand their knowledge and discuss the latest advancements has never been so important,” explained Professor Natasja de Groot, EHRA Scientific Programme Committee Co-Chair. “Guided by the theme, ‘Illuminating arrhythmia management’, this year’s programme will spotlight the innovations that are transforming the field. For example, a new Digital Cardiology track will discuss various ways that digital methods, including artificial intelligence, can be incorporated in our daily practice to improve aspects such as risk prediction, diagnosis and monitoring.”

“This edition is bold,” said Doctor Stylianos Tzeis, EHRA Scientific Programme Committee Co-Chair. “We are not just discussing the latest techniques and devices – we are bringing them to life through practical sessions and hands-on workshops.” He highlights Live Cases performed by international experts and the Simulation Village where participants can enhance their own practical skills.

Over 100 scientific submissions were made to this year’s Late-Breaking Science programme. “The number of submissions has doubled in 2026 compared with 2025, but it is not only the quantity that is high – the quality of the trials is impressive,” said Professor Jose Luis Merino, EHRA Scientific Programme Committee Member and EHRA Past President. One of the main topics covered in the Late-Breaking Science programme involves optimising the management of patients with heart failure who require cardiac resynchronisation therapy. Other Late-Breaking Science presentations focus on different ablation techniques to treat the increasing numbers of patients with atrial fibrillation, exploring ways to provide more effective treatment in a faster time.

Expert-driven clinical advice will be unveiled in new scientific statements developed by EHRA in collaboration with other ESC Associations and other international heart rhythm societies. This includes a statement from EHRA and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on echocardiography imaging from within the heart during invasive electrophysiological procedures.

The patient voice will be heard loud and clear in Paris with five sessions that have been designed to provide a stage for patients to share their experiences. “With all the discussions on advanced techniques and the latest therapies, it is important that we as healthcare professionals remain in touch with how arrhythmias and their treatment impact our patients’ lives,” noted Doctor Tzeis. “With new data, new technologies and new perspectives, EHRA 2026 promises to enlighten us all,” he concluded.

ENDS